UroLift continues to do well in "real world" studies
Results of UroLift were evaluated in a group of 2000 patients. Of these patients, 153 required some type of intervention during follow up. The overall reintervention rate was calculated at 6% per year. Of the 153 patients undergoing a secondary procedure, approximately half moved on to TURP, 1/3 underwent repeat UroLift, and less than 20% had their UroLift implants removed. An overall success rate of 94% per year, coupled with the minimally invasive procedure and the ability to further treat minimally invasively if needed, I believe solidifies UroLift as the "go-to" initial treatment for men with significant lower urinary tract symptoms.